Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC28A1 | O00337 | 1/20 | 0.78 |
| ▸ | SLC28A2 | O43868 | 1/20 | 0.78 |
| ▸ | SLC29A1 | Q99808 | 1/20 | 0.78 |
| ▸ | SLC28A3 | Q9HAS3 | 1/20 | 0.78 |
| ▸ | P2RY2 | P41231 | 13/20 | 0.67 |
| ▸ | P2RY6 | Q15077 | 9/20 | 0.63 |
| ▸ | P2RY4 | P51582 | 5/20 | 0.62 |
| ▸ | P2RY14 | Q15391 | 3/20 | 0.61 |
| ▸ | ENPP1 | P22413 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4452459 | 0.88 | SLC28A1 (0.61) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY2 | |
| Uridine SCHEMBL8590899 | 0.87 | SLC28A1 (1.00) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY2 | |
| Uridine SCHEMBL2912983 | 0.87 | SLC28A1 (1.00) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY2 | |
| Uridine SCHEMBL889616 | 0.87 | SLC28A1 (1.00) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY2 | |
| Uridine SCHEMBL2056530 | 0.87 | SLC28A1 (1.00) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY2 | |
| Uridine SCHEMBL16273806 | 0.87 | SLC28A1 (1.00) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY2 | |
| Uridine SCHEMBL2056634 | 0.87 | SLC28A1 (1.00) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY2 | |
| Uridine SCHEMBL4455604 | 0.87 | SLC28A1 (1.00) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY2 | |
| Uridine SCHEMBL20987631 | 0.87 | SLC28A1 (1.00) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY2 | |
| Uridine SCHEMBL890304 | 0.87 | SLC28A1 (1.00) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 3442 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026088119-A1 | LIPIDATED TLR7/8 MODULATORS AS ADJUVANTS AND USES THEREOF | PFIZER INC. (US) | 2026-04-30 | — | — | WO | claimed |
| EP-4092139-B1 | METHOD FOR DISCRIMINATING BETWEEN LIVE AND DEAD MICROBES IN A SAMPLE | PATHOQUEST (FR) | 2026-02-18 | — | — | EP | claimed |
| EP-4630049-A1 | IMMUNOGENIC COMPOSITIONS AGAINST INFLUENZA AND RSV | Pfizer Inc. (US) | 2025-10-15 | — | — | EP | claimed |
| EP-4612300-A1 | METHODS FOR MESSENGER RNA TAILING | Sanofi Pasteur Inc. (US) | 2025-09-10 | — | — | EP | claimed |
| CN-120158462-A | MRNA vaccine encoding varicella zoster virus glycoprotein E | 中生复诺健生物科技(上海)有限公司 | 2025-06-17 | — | — | CN | claimed |
| CN-120153078-A | RNA molecules encoding RSV-F and vaccines containing the same | 辉瑞大药厂 | 2025-06-13 | — | — | CN | claimed |
| CN-112585283-B | Method for distinguishing live microorganism from dead microorganism in sample | 帕特霍奎斯特公司 | 2025-05-23 | — | — | CN | claimed |
| CN-120019152-A | Artificial polynucleotides for expressing proteins | 塞提斯生物技术有限公司 | 2025-05-16 | — | — | CN | claimed |
| CN-119947747-A | Influenza virus vaccine | 葛兰素史克生物有限公司 | 2025-05-06 | — | — | CN | claimed |
| CN-119866376-A | Self-amplifying RNA encoding influenza virus antigen | 辉瑞公司 | 2025-04-22 | — | — | CN | claimed |
| US-20110287412-A1 | Methods for Identifying RNA Segments Bound by RNA-Binding Proteins or Ribonucleoprotein Complexes | ROCKEFELLER UNIVERSITY (US) | 2011-11-24 | — | — | US | claimed |
| WO-2011005799-A2 | SELF REPLICATING RNA MOLECULES AND USES THEREOF | NOVARTIS AG (CH) | 2011-01-13 | — | — | WO | claimed |
| US-20100254901-A1 | Compositions comprising nucleic acid aptamers | SMITH CASSANDRA L | 2010-10-07 | — | — | US | claimed |
| WO-2010014636-A1 | METHODS FOR IDENTIFYING RNA SEGMENTS BOUND BY RNA-BINDING PROTEINS OR RIBONUCLEOPROTEIN COMPLEXES | ROCKEFELLER UNIVERSITY (US) | 2010-02-04 | — | — | WO | claimed |
| US-20090053169-A1 | Oligonucleotide Core Carrier Compositions for Delivery of Nucleic Acid-Containing Therapeutic Agents, Methods of Making and Using the Same | PHARMAIN CORPORATION (US) | 2009-02-26 | — | — | US | claimed |
| WO-2001007013-A9 | THIOAMIDE MOIETY-CONTAINING POLYMER DRUG CONJUGATES | UNIV NEW JERSEY MED (US) | 2002-11-14 | — | — | WO | claimed |
| US-6468522-B1 | Controlled release of thioamide moiety-containing therapeutic agents | UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY | 2002-10-22 | — | — | US | claimed |
| US-20020122785-A1 | Materials and processes for controlled release of thioamide moiety-containing therapeutic agents by linking to thiol-containing polymers | STEIN STANLEY (US) | 2002-09-05 | — | — | US | claimed |
| WO-2001007013-A2 | THIOAMIDE MOIETY-CONTAINING POLYMER DRUG CONJUGATES | UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY (US) | 2001-02-01 | — | — | WO | claimed |
| US-4954485-A | AUTOIMMUNE DISEASES | SANYO-KOKUSAKU PULP CO., LTD. (JP) | 1990-09-04 | — | — | US | claimed |